National Survey on Infiltrative Breast Cancer (CSI)

AstraZeneca

Status: Completed

Conditions: Infiltrative Breast Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT00696527

NIS-OFR-DUM-2007/1

Details and patient eligibility

About

The purpose of this observational study is to describe radiological, clinical and histological characteristics of women with infiltrative breast cancer.

Enrollment: 1,500 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women> or = 18 years old
• Women with newly diagnosis of infiltrative breast cancer
• Agree to take part in this study

Exclusion criteria

• Women with other malignant tumor (except in situ cervical carcinoma or treated basal cell carcinoma)
• Women with in situ ductal carcinoma or in situ lobular carcinoma

Trial design

1,500 participants in 1 patient group

1